ERBB2 and neoplasm: As shown in Figs. 4A and S3, in the HER2high+ mouse model, the rates of tumor growth were considerably inhibited by treatment with CART-HER2 cells, while tumors in the control group continued to grow rapidly after the injection with NT T cells.